In humans, corticotropin releasing hormone antagonizes some of the negative immunoregulatory effects of serotonin

Neuroendocrinology Letters

Volumn 24, Issue 6, 2003, Pages 420-424

  Maes, Michael ^a,b   Kenis, Gunter ^b   Kubera, Marta ^a   Bosmans, Eugene ^b  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Corticotropin releasing hormone; Cytokines; Serotonin; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIOASSAY; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOREGULATION; INFLAMMATION; MALE; NORMAL HUMAN; STATISTICAL ANALYSIS;

EID: 0347693073     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. De Souza EB, Grigoriadis DE, Webster EL. Role of brain, pituitary and spleen corticotropin-releasing factor receptors in the stress response. Methods Achiev Exp Pathol 1991; 14:23-44.
2. Chaouloff F. Serotonin, stress and corticoids. J Psychopharmacol 2000; 14:139-151.
3. Maes M. Psychological stress, cytokines and the inflammatory response system. Curr Opinion Psychiatry 1999; 12:695-700.
4. Singh VK, Leu SJ. Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neurosci Lett 1990; 120:151-154.
5. Paez Pereda M, Sauer J, Perez Castro C, Finkielman S, Stalla GK, Holsboer F, Arzt E. Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology 1995; 136: 5504-5510.
6. Leu S-J C, Singh VK. Stimulation of interleukin-6 production by corticotropin-releasing factor. Cellul Immunol 1992; 143: 220-227.
7. Singh VK. Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J Neuroimmunol 1989; 23:257-262.
8. Angioni S, Petraglia F, Gallinelli A, Cossarizza A, Franceschi C, Muscettola M, Genazzani AD, Surico N, Genazzani AR. Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Life Sci 1993; 53: 1735-1742.
9. Hagan P, Poole S, Bristow AF. Immunosuppressive activity of corticotrophin-releasing factor. Inhibition of interleukin-1 and interleukin-6 production by human mononuclear cells. Biochem J 1992; 281( Pt 1):251-254.
10. Kubera M, Kenis G, Bosmans E, Scharpe S, Maes M. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10. Neuropsychopharmacology 2000; 23:89-98.
11. Katsikis PD, Cohen SB, Londei M, Feldmann M. Are CD4+ Th1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-gamma or IL-2 determines their function. Int Immunol 1995; 7:1287-1294.
12. Markstein R, Matsumoto M, Kohler C, Togashi H, Yoshioka M, Hoyer D. Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 1999; 359:454-459.
13. Benbernou N, Esnault S, Shin HCK, Fekkar H, Guenounou M. Differential regulation of IFN-γ, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology 1997; 91:361-368.
14. Platzer C, Meisel C, Vogt K, Platzer M, Volk HD. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol 1995; 7:517-523.
15. Eigler A, Matschke V, Hartmann G, Erhardt S, Boyle D, Firestein GS, Endres S. Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor. J Leukoc Biol 2000; 68:97-103.
16. Zhang LM, Castresana MR, Shaker IJ, Dalton ML, Leeper-Wood-ford SK, Newman WH. Increased intracellutar cyclic adenosine 3′, 5′-monophosphate inhibits release of tumor necrosis factor-alpha from human vascular tissue and cultured smooth muscle cells. Critical Care Med 1997; 25:1855-1861.
17. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association, Washington DC.
18. Maes M, Song C, Lin A-H, Bonaccorso S, Kenis G, De Jongh R, Bosmans E, Scharpe S. Negative immunoregulatory effects of antidepressants: inhibition of interferon-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology 1999; 20: 370-379.
19. Maes M, Song C, Lin A, de Jongh R, Van Gastel A, Kenis G, Bosmans E, De Meester I, Benoy I, Neets H, Demedts P, Janca A, Scharpe S, Smith RS. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 1998; 10: 313-318.
20. De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat-Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I, Igot D, Baudrihaye M, Delacroix D, Franchimont P. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992; 4:239-248.
21. De Groote D, Gevaert Y, Lopez M, Gathy R, Fauchet F, Dehart I, Jadoul M, Radoux D, Franchimont P. Novel method for the measurement of cytokine production by one-stage procedure. J Immunol Methods 1993; 9:259-267.
22. Zangerle PF, De Groote D, Lopez M, Meuteman RJ, Vrindts Y, Fauchet F, Dehart I, Jadoul M, Radoux D, Franchimont P. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 1992; 4: 568-575.
23. Audhya T, Jain R, Hollander CS. Receptor-mediated immunomodulation by corticotropin-releasing factor. Cell Immunol 1991; 134:77-84.
24. Singh VK, Fudenberg HH. Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease. Immumol Lett 1988; 18:5-8.
25. Arzt E, Costas M, Finkielman S, Nahmod VE. Serotonin inhibition of tumor necrosis factor-alpha synthesis by human monocytes. Life Sci 1991; 48:2557-2562.
26. Kawashima S, Hayashi M, Takii T, Kimura H, Zhang HL, Nagatsu A, Sakakibara J, Murata K, Oomoto Y, Onozaki K. Serotonin derivative, N-(p-coumaroyl) serotonin, inhibits the production of TNF-alpha, IL-1alpha, IL-1beta, and IL-6 by endotoxin-stimulated human blood monocytes. J Interferon Cytokine Res 1998; 18:423-428.
27. Kubera M, Maes M. Serotonin-immune interactions in major depression. In: Patterson, P.H., Kordon, C., Christen, Y. (Eds.) Neuroimmune Interactions in Neurologic and Psychiatric Disorders. Springer Verlag, Fondation IPSEN, Paris, 1999, pp. 79-88.
28. Grimaldi B, Sibella-Arguelles C, Bonnin A, Fillion MP, Massot O, Rousselle JC, Seznec JC, Fillion G. Functional properties of 5-HT-moduline in the immune system: a model for central nervous system investigation. Ann NY Acad Sci 1998; 861:249-250.
29. Graveleau C, Faust HJ, Schmidt-Grimminger D, Mukhopadhyay AK. Presence of a 5-HT7 receptor positively coupled to adenylate cyclase activation in human granulosa-lutein cells. J Clin Endocrinol Metabol 2000; 85:1277-1286.
30. Stefulj J, Jernej B, Cicin-Sain L, Rinner I, Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Beh Immun 2000; 14:219-224.
31. Smith EM, Morrill AC, Meyer WJ 3rd, Blalock JE. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 1986; 321:881-882.
32. Webster EL, Torpy DJ, Elenkov IJ, Chrousos GP. Corticotropin-releasing hormone and inflammation. Ann NY Acad Sci 1998; 840: 21-32.